发布求助
文献互助 智能选刊 最新文献

Clinical and Molecular Hepatology最新文献

筛选
英文 中文
Letter regarding "Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis". 关于 "减肥干预可改善肥胖症患者的代谢功能障碍相关性脂肪性肝炎：系统回顾和荟萃分析"。
IF 8.9 1区 医学
Clinical and Molecular Hepatology Pub Date : 2024-09-12 DOI: 10.3350/cmh.2024.0784
Xiao-Song Li,Xi-Ping Shen,Hang Li
{"title":"Letter regarding \"Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis\".","authors":"Xiao-Song Li,Xi-Ping Shen,Hang Li","doi":"10.3350/cmh.2024.0784","DOIUrl":"https://doi.org/10.3350/cmh.2024.0784","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":null,"pages":null},"PeriodicalIF":8.9,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142182153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correspondence on Editorial regarding "Spotting Undiagnosed Significant Liver Fibrosis in the General Population: Impact on Subsequent Clinical Care". 关于 "发现普通人群中未确诊的严重肝纤维化：对后续临床治疗的影响 "的社论。
IF 8.9 1区 医学
Clinical and Molecular Hepatology Pub Date : 2024-09-11 DOI: 10.3350/cmh.2024.0777
Hee Yeon Kim,Miyoung Choi,Dae Won Jun
{"title":"Correspondence on Editorial regarding \"Spotting Undiagnosed Significant Liver Fibrosis in the General Population: Impact on Subsequent Clinical Care\".","authors":"Hee Yeon Kim,Miyoung Choi,Dae Won Jun","doi":"10.3350/cmh.2024.0777","DOIUrl":"https://doi.org/10.3350/cmh.2024.0777","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":null,"pages":null},"PeriodicalIF":8.9,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142182152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correspondence on Editorial regarding "KCTD17 as a RAS stabilizer in hepatocellular carcinoma progression". 关于 "KCTD17 作为肝细胞癌进展过程中的 RAS 稳定剂 "社论的通信。
IF 8.9 1区 医学
Clinical and Molecular Hepatology Pub Date : 2024-09-10 DOI: 10.3350/cmh.2024.0750
Sang Bae Lee,KyeongJin Kim
{"title":"Correspondence on Editorial regarding \"KCTD17 as a RAS stabilizer in hepatocellular carcinoma progression\".","authors":"Sang Bae Lee,KyeongJin Kim","doi":"10.3350/cmh.2024.0750","DOIUrl":"https://doi.org/10.3350/cmh.2024.0750","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":null,"pages":null},"PeriodicalIF":8.9,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142223796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correspondence on Letter regarding "A complement to epigenetics in MASLD". 关于 "MASLD 中表观遗传学的补充 "信函的通信。
IF 8.9 1区 医学
Clinical and Molecular Hepatology Pub Date : 2024-09-10 DOI: 10.3350/cmh.2024.0761
Amal Magdy,Hee-Jin Kim,Won Kim,Mirang Kim
{"title":"Correspondence on Letter regarding \"A complement to epigenetics in MASLD\".","authors":"Amal Magdy,Hee-Jin Kim,Won Kim,Mirang Kim","doi":"10.3350/cmh.2024.0761","DOIUrl":"https://doi.org/10.3350/cmh.2024.0761","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":null,"pages":null},"PeriodicalIF":8.9,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142182150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PNPLA3 is one of the bridges between TM6SF2 E167K variant and MASLD. PNPLA3 是 TM6SF2 E167K 变体与 MASLD 之间的桥梁之一。
IF 8.9 1区 医学
Clinical and Molecular Hepatology Pub Date : 2024-09-10 DOI: 10.3350/cmh.2024.0744
Baokai Sun,Likun Zhuang
{"title":"PNPLA3 is one of the bridges between TM6SF2 E167K variant and MASLD.","authors":"Baokai Sun,Likun Zhuang","doi":"10.3350/cmh.2024.0744","DOIUrl":"https://doi.org/10.3350/cmh.2024.0744","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":null,"pages":null},"PeriodicalIF":8.9,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142182151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spotting Undiagnosed Significant Liver Fibrosis in the General Population: Impact on Subsequent Clinical Care. 发现普通人群中未确诊的严重肝纤维化：对后续临床治疗的影响。
IF 14 1区 医学
Clinical and Molecular Hepatology Pub Date : 2024-09-03 DOI: 10.3350/cmh.2024.0737
Nana Peng, Mary Yue Wang, Sherlot Juan Song, Terry Cheuk-Fung Yip
{"title":"Spotting Undiagnosed Significant Liver Fibrosis in the General Population: Impact on Subsequent Clinical Care.","authors":"Nana Peng, Mary Yue Wang, Sherlot Juan Song, Terry Cheuk-Fung Yip","doi":"10.3350/cmh.2024.0737","DOIUrl":"https://doi.org/10.3350/cmh.2024.0737","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":null,"pages":null},"PeriodicalIF":14.0,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142125002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Personalized Approaches to the Treatment of Hepatocellular Carcinoma Using Immune Checkpoint Inhibitors. 使用免疫检查点抑制剂治疗肝细胞癌的个性化方法。
IF 14 1区 医学
Clinical and Molecular Hepatology Pub Date : 2024-09-03 DOI: 10.3350/cmh.2024.0739
Naoshi Nishida
{"title":"Personalized Approaches to the Treatment of Hepatocellular Carcinoma Using Immune Checkpoint Inhibitors.","authors":"Naoshi Nishida","doi":"10.3350/cmh.2024.0739","DOIUrl":"https://doi.org/10.3350/cmh.2024.0739","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":null,"pages":null},"PeriodicalIF":14.0,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142125001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma. 晚期肝细胞癌中的索拉非尼与仑伐替尼对比。
IF 14 1区 医学
Clinical and Molecular Hepatology Pub Date : 2024-09-02 DOI: 10.3350/cmh.2024.0682
Meng-Che Wu, Hui-Chin Chang, Yi-Sheng Jhang, Shuo-Yan Gau
{"title":"Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma.","authors":"Meng-Che Wu, Hui-Chin Chang, Yi-Sheng Jhang, Shuo-Yan Gau","doi":"10.3350/cmh.2024.0682","DOIUrl":"https://doi.org/10.3350/cmh.2024.0682","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":null,"pages":null},"PeriodicalIF":14.0,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142104910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcriptomic signature in advanced hepatocellular carcinoma tissue to predict combination immunotherapy response. 预测联合免疫疗法反应的晚期肝细胞癌组织转录组特征。
IF 14 1区 医学
Clinical and Molecular Hepatology Pub Date : 2024-08-30 DOI: 10.3350/cmh.2024.0726
Hiroaki Kanzaki, Yujin Hoshida
{"title":"Transcriptomic signature in advanced hepatocellular carcinoma tissue to predict combination immunotherapy response.","authors":"Hiroaki Kanzaki, Yujin Hoshida","doi":"10.3350/cmh.2024.0726","DOIUrl":"https://doi.org/10.3350/cmh.2024.0726","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":null,"pages":null},"PeriodicalIF":14.0,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142104911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling the distinctive gut microbiota and metabolites in liver cirrhosis and its complications: Novel diagnostic biomarkers. 揭示肝硬化及其并发症中独特的肠道微生物群和代谢物：新的诊断生物标志物。
IF 14 1区 医学
Clinical and Molecular Hepatology Pub Date : 2024-08-30 DOI: 10.3350/cmh.2024.0716
Soon Kyu Lee, Jong Young Choi
{"title":"Unveiling the distinctive gut microbiota and metabolites in liver cirrhosis and its complications: Novel diagnostic biomarkers.","authors":"Soon Kyu Lee, Jong Young Choi","doi":"10.3350/cmh.2024.0716","DOIUrl":"https://doi.org/10.3350/cmh.2024.0716","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":null,"pages":null},"PeriodicalIF":14.0,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142104912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信